Monitoring vitamin D concentrations in patients with osteoporosis: a clinical perspective
- PMID: 20180605
- DOI: 10.1592/phco.30.3.224
Monitoring vitamin D concentrations in patients with osteoporosis: a clinical perspective
Comment on
-
Is there a role for therapeutic drug monitoring of vitamin D level as a surrogate marker for fracture risk?Pharmacotherapy. 2010 Mar;30(3):254-64. doi: 10.1592/phco.30.3.254. Pharmacotherapy. 2010. PMID: 20180609 Review.
Similar articles
-
[Vitamin D in geriatric patients].Internist (Berl). 2020 Jun;61(6):535-540. doi: 10.1007/s00108-020-00803-2. Internist (Berl). 2020. PMID: 32458373 Review. German.
-
Is there a role for therapeutic drug monitoring of vitamin D level as a surrogate marker for fracture risk?Pharmacotherapy. 2010 Mar;30(3):254-64. doi: 10.1592/phco.30.3.254. Pharmacotherapy. 2010. PMID: 20180609 Review.
-
[Recommendations for calcium and vitamin D in the report 'Nutritional standards' of the Netherlands Health Council].Ned Tijdschr Geneeskd. 2000 Oct 14;144(42):1991-4. Ned Tijdschr Geneeskd. 2000. PMID: 11072516 Review. Dutch.
-
[Vitamine D in patients with osteoporosis: sufficient or necessary?].Rev Med Suisse. 2007 Jun 13;3(115):1515-6, 1518-20. Rev Med Suisse. 2007. PMID: 17682795 French.
-
Vitamin D and falls - the dosage conundrum.Nat Rev Endocrinol. 2016 Nov;12(11):680-684. doi: 10.1038/nrendo.2016.123. Epub 2016 Aug 5. Nat Rev Endocrinol. 2016. PMID: 27494391 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical